Brokerages Set UiPath Inc. (NYSE:PATH) Target Price at $17.71

UiPath Inc. (NYSE:PATHGet Free Report) has been assigned a consensus rating of “Hold” from the eighteen ratings firms that are presently covering the firm, MarketBeat reports. Sixteen equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $17.71.

A number of analysts have recently issued reports on PATH shares. Bank of America lifted their price objective on shares of UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Evercore ISI raised their target price on shares of UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a research note on Friday, September 6th. Morgan Stanley reissued an “equal weight” rating and issued a $15.00 target price on shares of UiPath in a research note on Friday, September 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a research report on Friday, September 6th. Finally, Wells Fargo & Company lifted their price objective on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research report on Friday, September 6th.

Get Our Latest Stock Report on UiPath

Insiders Place Their Bets

In other news, CFO Ashim Gupta sold 47,671 shares of the company’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now owns 849,917 shares of the company’s stock, valued at $10,258,498.19. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 22.37% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Pacer Advisors Inc. bought a new position in shares of UiPath during the 2nd quarter worth approximately $69,180,000. Vanguard Group Inc. raised its position in shares of UiPath by 5.6% during the first quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock worth $911,741,000 after purchasing an additional 2,133,078 shares during the period. Renaissance Technologies LLC acquired a new position in shares of UiPath during the second quarter worth approximately $13,280,000. AQR Capital Management LLC raised its position in shares of UiPath by 120.6% during the second quarter. AQR Capital Management LLC now owns 1,633,393 shares of the healthcare company’s stock worth $20,385,000 after purchasing an additional 892,845 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in shares of UiPath by 37.2% during the second quarter. Dimensional Fund Advisors LP now owns 2,783,571 shares of the healthcare company’s stock worth $35,296,000 after purchasing an additional 754,519 shares during the period. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Stock Performance

Shares of PATH stock opened at $12.29 on Tuesday. The company has a market capitalization of $7.04 billion, a P/E ratio of -76.81 and a beta of 0.88. The company’s 50 day moving average price is $12.18 and its two-hundred day moving average price is $15.06. UiPath has a 52 week low of $10.37 and a 52 week high of $27.87.

UiPath (NYSE:PATHGet Free Report) last announced its earnings results on Thursday, September 5th. The healthcare company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.03 by $0.01. The firm had revenue of $316.00 million for the quarter, compared to the consensus estimate of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period last year, the company posted ($0.09) EPS. Analysts forecast that UiPath will post -0.23 earnings per share for the current year.

UiPath Company Profile

(Get Free Report

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Further Reading

Analyst Recommendations for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.